In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...
Specifically, Buck brews and quaffs a hazy beer that induces immunity against the BK virus, also known as human polyomavirus.
French pharma major Sanofi (Euronext: SAN) will supply 600,000 doses of its protein-based COVID-19 vaccine Nuvaxovid ...
To further expand its global presence and ensure widespread vaccine availability, SII has established Serum Life Sciences Ltd, a subsidiary in the UK. Through relentless pursuit of innovation, SII ...
Moderna CEO Stéphane Bancel’s total compensation remained remarkably stable last year at $19.9 million, even as the vaccines company navigated a “challenging regulatory and business environment.” ...
Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, has received marketing authorization from the Drug ...
Top Taiwan brand joins forces with Substipharm Biologics to expand South-East Asian market and help improve young children's ...
Vietnam Investment Review on MSN
SK bioscience secures funding for RSV antibody development
INCHEON, South Korea, March 18, 2026 /PRNewswire/ -- SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health Technology Foundation ...
Tribune Online on MSN
EU urged to champion health equity in global pandemic pact
The AIDS Healthcare Foundation (AHF) has called on the European Union to stop blocking stronger equity provisions in the Pathogen Access and Benefit Sharing (PABS) Annex of the World Health ...
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street ...
Vaccine hesitancy is widely recognized as one of the most significant public health problems of the 21 st Century. The World Health Organization (WHO) identifies vaccine hesitancy ...
With a May 2026 deadline approaching, health advocates cautioned that failure to reach consensus could undermine global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results